Titre : Produits du tabac

Produits du tabac : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit Disorder with Hyperactivity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Produits du tabac : Questions médicales les plus fréquentes", "headline": "Produits du tabac : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Produits du tabac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-05-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Produits du tabac" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dispositifs pour fumer", "url": "https://questionsmedicales.fr/mesh/D000074602", "about": { "@type": "MedicalCondition", "name": "Dispositifs pour fumer", "code": { "@type": "MedicalCode", "code": "D000074602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Tabac sans fumée", "alternateName": "Tobacco, Smokeless", "url": "https://questionsmedicales.fr/mesh/D014030", "about": { "@type": "MedicalCondition", "name": "Tabac sans fumée", "code": { "@type": "MedicalCode", "code": "D014030", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844.500" } } }, { "@type": "MedicalWebPage", "name": "Tabac pour pipe à eau", "alternateName": "Tobacco, Waterpipe", "url": "https://questionsmedicales.fr/mesh/D000073846", "about": { "@type": "MedicalCondition", "name": "Tabac pour pipe à eau", "code": { "@type": "MedicalCode", "code": "D000073846", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.767.844.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Produits du tabac", "alternateName": "Tobacco Products", "code": { "@type": "MedicalCode", "code": "D062789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Takahiro Tabuchi", "url": "https://questionsmedicales.fr/author/Takahiro%20Tabuchi", "affiliation": { "@type": "Organization", "name": "Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan." } }, { "@type": "Person", "name": "Jennifer B Unger", "url": "https://questionsmedicales.fr/author/Jennifer%20B%20Unger", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America." } }, { "@type": "Person", "name": "Pamela M Ling", "url": "https://questionsmedicales.fr/author/Pamela%20M%20Ling", "affiliation": { "@type": "Organization", "name": "Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California." } }, { "@type": "Person", "name": "Silvano Gallus", "url": "https://questionsmedicales.fr/author/Silvano%20Gallus", "affiliation": { "@type": "Organization", "name": "Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy." } }, { "@type": "Person", "name": "Jessica L Barrington-Trimis", "url": "https://questionsmedicales.fr/author/Jessica%20L%20Barrington-Trimis", "affiliation": { "@type": "Organization", "name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/36342984", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.12740/PP/OnlineFirst/130366" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/36927130", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10870547231161531" } }, { "@type": "ScholarlyArticle", "name": "Pragmatic Deficits in Attention Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis.", "datePublished": "2023-03-28", "url": "https://questionsmedicales.fr/article/36975307", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10870547231161534" } }, { "@type": "ScholarlyArticle", "name": "Oculomotor deficits in attention deficit hyperactivity disorder: a systematic review and meta-analysis.", "datePublished": "2022-10-24", "url": "https://questionsmedicales.fr/article/36280758", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41433-022-02284-z" } }, { "@type": "ScholarlyArticle", "name": "Characterizing the metabolomic signature of attention-deficit hyperactivity disorder in twins.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37100381", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuropharm.2023.109562" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Dispositifs pour fumer", "item": "https://questionsmedicales.fr/mesh/D000074602" }, { "@type": "ListItem", "position": 5, "name": "Produits du tabac", "item": "https://questionsmedicales.fr/mesh/D062789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Produits du tabac - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Produits du tabac", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Produits du tabac", "description": "Comment diagnostiquer une dépendance au tabac ?\nQuels tests pour évaluer les effets du tabac ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Produits du tabac", "description": "Quels sont les symptômes d'une intoxication au tabac ?\nComment le tabac affecte-t-il la respiration ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Produits du tabac", "description": "Comment prévenir le tabagisme chez les jeunes ?\nLes lois anti-tabac sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Produits du tabac", "description": "Quels traitements existent pour arrêter de fumer ?\nLes thérapies comportementales sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Produits du tabac", "description": "Quelles sont les complications du tabagisme ?\nLe tabac augmente-t-il le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Produits du tabac", "description": "Quels sont les facteurs de risque du tabagisme ?\nLe stress influence-t-il la consommation de tabac ?", "url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dépendance au tabac ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage." } }, { "@type": "Question", "name": "Quels tests pour évaluer les effets du tabac ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication au tabac ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques." } }, { "@type": "Question", "name": "Comment le tabac affecte-t-il la respiration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir le tabagisme chez les jeunes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles." } }, { "@type": "Question", "name": "Les lois anti-tabac sont-elles efficaces ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition." } }, { "@type": "Question", "name": "Quels traitements existent pour arrêter de fumer ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale." } }, { "@type": "Question", "name": "Les thérapies comportementales sont-elles efficaces ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme." } }, { "@type": "Question", "name": "Quelles sont les complications du tabagisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques." } }, { "@type": "Question", "name": "Le tabac augmente-t-il le risque de cancer ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du tabagisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux." } }, { "@type": "Question", "name": "Le stress influence-t-il la consommation de tabac ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants." } } ] } ] }

Sources (10000 au total)

Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.

To assess attachment styles among adolescents (13-16 years) with ADHD or ADHD and oppositional defiant disorders (ODD).... The Parents and Peers Attachment (IPPA) and the Parent Bonding Questionnaire (PBI) were used in three groups of teenagers raised in biological families: (1) ADHD/ODD group (n = 40), (2) ADHD group (n ... Parental attachment styles in the area of "Trust", "Communication" and "Alienation" (IPPA), and "Care" and "Control" (PBI) in the ADHD/ODD group differ significantly compared to the control group. Tee... The attachment style is significantly different in adolescents diagnosed with ADHD and ODD than in adolescents with only ADHD. In the ADHD/ODD group and the ADHD group, unlike in the group of adolesce...

Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

To estimate the prevalence of PDs according to Millon's evolution-based model among adult ADHD outpatients.... Cross-sectional study of consecutive patients referred to an adult ADHD clinic. PDs were evaluated with Millon Clinical Multiaxial Inventory-III (MCMI-III).... One-hundred-eighty-one participants had valid MCMI-III, of whom147 were diagnosed with ADHD. Mean age: 32.97, SD:11.56, females: 74 (50.3%). Among the 147 participants with ADHD, 29 (19.7%) did not me... Particular personality profiles were more common with different ADHD subtypes. Given the developmental origins of PD, further research may help identify possible links with childhood difficulties....

Pragmatic Deficits in Attention Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis.

While poorer pragmatic language skills have been found in attention-deficit/hyperactivity disorder (ADHD) populations, there has been no conclusive evidence of this. We aimed to conduct a meta-analysi... Studies were identified using the search terms ((attention deficit) OR (adhd)) AND (pragmatics), and those studies were screened and reviewed for inclusion criteria, descriptive information, and outco... A total of 14 studies (5,772 participants) met the criteria for quantitative synthesis. Meta-analysis indicated that ADHD populations exhibited significantly poorer pragmatic language skills than TD p... It is suggested that pragmatic language skills may deserve greater surveillance considering the importance of pragmatic language in socio-emotional development, daily life, and academic success....

Attention deficit and hyperactivity disorder disrupts selective mechanisms of action.

People with attention deficit and hyperactivity disorder (ADHD) present attentional and emotional deficits and show paradoxical qualities such as hyperfocus. Previous studies have reported errors, slo... Thirty French children and teenagers, 15 with ADHD and 15 neurotypical (NT), underwent a saccadic eye movement task. We conducted conventional analysis (movement duration, precision, velocity, RT) and... Saccade duration and velocity failed to differentiate the two groups, whereas amplitude was higher in ADHD than in NT participants. Saccade RT and variability were higher in ADHD than in NT participan... ADHD disrupts two mechanisms of action: it reduces the gain of the decision signal, thus explaining slowness and variability; it quickens the decision process of early responses at the origin of short... These premises and their interconnections explain previous observations and support the striatal-frontal wiring of ADHD, thus explaining ADHD complexity in its negative and positive manifestations....

Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder.

The association between attention-deficit/hyperactivity disorder (ADHD) and schizophrenia has received increased attention; however, evidence on the association between psychiatric comorbidities and s... To investigate the risk of being diagnosed with schizophrenia in children and adolescents with ADHD considering the presence of psychiatric comorbidity.... This was a population-based, retrospective cohort study using the Health Insurance Review and Assessment claims database from January 1, 2007, to December 31, 2019. Participants were children and adol... The presence of psychiatric comorbidity was assessed from diagnosis records within 1 year before ADHD diagnosis. Comorbidities were further categorized according to the number of comorbidities and spe... Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs, examining the association between psychiatric comorbidities and the risk of being diagnosed with schizophrenia. Fu... A total of 211 705 patients with newly diagnosed ADHD were included. A total of 157 272 patients (74.3%) were male, and the age of 5 to 9 years showed the highest distribution (115 081 patients [54.4%... In this retrospective cohort study involving children and adolescents with ADHD, the presence of psychiatric comorbidity in patients with ADHD was associated with an increased risk of being diagnosed ...